INmune Bio

$11.93 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About INmune Bio

INmune Bio Inc. operates as a clinical stage biotechnology company. The Company develops medicines to treat cancer. INmune Bio serves clients in the United States.

Stock Analysis

last close $11.22
1-mo return -42.5%
3-mo return -57.5%
avg daily vol. 307.99T
52-week high 30.37
52-week low 8.4
market cap. $200M
forward pe -
annual div. -
roe -36.9%
ltg forecast -
dividend yield -
annual rev. $0M
inst own. 11%
baraka

Subscribe now for daily local and international financial news

Subscribe